Next Article in Journal
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
Next Article in Special Issue
Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year Analysis
Previous Article in Journal
Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma
Previous Article in Special Issue
Acetylated DNMT1 Downregulation and Related Regulatory Factors Influence Metastatic Melanoma Patients Survival
 
 
Article

Article Versions Notes

Cancers 2021, 13(19), 4781; https://doi.org/10.3390/cancers13194781
Action Date Notes Link
article xml file uploaded 24 September 2021 15:38 CEST Original file -
article xml uploaded. 24 September 2021 15:38 CEST Update -
article pdf uploaded. 24 September 2021 15:38 CEST Version of Record https://www.mdpi.com/2072-6694/13/19/4781/pdf-vor
article supplementary file uploaded. 24 September 2021 15:38 CEST - https://www.mdpi.com/2072-6694/13/19/4781#supplementary
article html file updated 24 September 2021 15:39 CEST Original file -
article xml file uploaded 26 September 2021 04:22 CEST Update -
article xml uploaded. 26 September 2021 04:22 CEST Update -
article pdf uploaded. 26 September 2021 04:22 CEST Updated version of record https://www.mdpi.com/2072-6694/13/19/4781/pdf-vor
article html file updated 26 September 2021 04:24 CEST Update -
article xml file uploaded 26 September 2021 04:50 CEST Update -
article xml uploaded. 26 September 2021 04:50 CEST Update https://www.mdpi.com/2072-6694/13/19/4781/xml
article pdf uploaded. 26 September 2021 04:50 CEST Updated version of record https://www.mdpi.com/2072-6694/13/19/4781/pdf
article html file updated 26 September 2021 04:51 CEST Update -
article html file updated 30 July 2022 07:30 CEST Update https://www.mdpi.com/2072-6694/13/19/4781/html
Back to TopTop